Home Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation
 

Keywords :   


Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation

2014-03-05 04:23:36| drugdiscoveryonline News Articles

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, recently announced an extension of its funded collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT)

Tags: common foundation extension collaboration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.07EU hits Chinese electric cars with steep tariffs
04.07Hurricane Beryl Forecast Discussion Number 23
04.07Hurricane Beryl Public Advisory Number 23
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Hurricane Beryl Wind Speed Probabilities Number 23
04.07Hurricane Beryl Forecast Advisory Number 23
04.07Atlantic Tropical Weather Outlook
04.07Eastern North Pacific Tropical Weather Outlook
More »